Related by context. All words. (Click for frequent words.) 71 kidney urologic 69 myelofibrosis polycythemia vera 69 CYT# potent vascular disrupting 68 ENMD # 67 antiangiogenesis therapies 67 sulfonylhydrazine class 67 pancreatic prostate 66 plasma kallikrein inhibitor 66 erlotinib Tarceva ® 66 interleukin IL -# 66 LymphoStat B belimumab 66 Delta opioid receptor 66 anaphylactic reactions bronchospasm 66 Angiolix 66 Darapladib 66 anti amnesic 66 telomerase inhibitor 66 sunitinib Sutent ® 66 sPLA2 66 specific lectin receptors 65 AKT inhibitor 65 LHRH antagonists 65 HGS ETR1 mapatumumab 65 Schering Plough Remicade 65 Viprovex R 65 peptide antigens 65 NuMimetic TM 65 Epidermal Growth Factor Receptor 65 D aspartate NMDA receptor 65 itraconazole Sporanox 65 novel peptide 65 anticancer therapeutics 65 AAG geldanamycin analog 65 molecular biomarkers 65 GRNOPC1 contains 65 immune modulatory 65 CEA CD# Her2 65 candidates Azedra TM 65 CD# monoclonal antibody 65 hypervascular tumors 65 imatinib Gleevec ® 65 PI3K Akt 65 Sphingomab 65 multi kinase inhibitor 65 pathophysiological effects 65 cytotoxin 65 oral Janus kinase 65 Locked Nucleic Acid LNA 64 delay bone metastases 64 vinca alkaloids 64 certain protein tyrosine 64 MCSP respectively 64 hypoxia selective 64 sorafenib tablets 64 tetracycline antibiotic 64 signal averaging electrocardiography 64 alpha#beta# integrin 64 preclinically 64 Interferons 64 mertansine 64 molecule interleukin 64 oral prodrug 64 5 HT2A inverse 64 selective kinase inhibitor 64 mediated autoimmune diseases 64 demonstrated anti amnesic 64 novel antibody therapeutics 64 Enzastaurin 64 vapreotide acetate 64 Rigel R# 64 Cathepsin B 64 cMET 64 K ras mutations 64 antiangiogenic activity 64 oral gallium 64 siRNA compounds 64 tubulin binding 64 diagnostic biomarkers 64 accumulate preferentially 64 oncolytic virus therapies 64 St. Downers Grove 64 inhibit EGFR 64 Warfarin Coumadin 64 PSMA ADC 64 treat chronic rhinosinusitis 64 small molecule agonists 64 targeting refractory relapsing 64 Mg Usa 64 Talabostat 64 MEK inhibitors 64 fusion enhancers 64 TNF Tumor Necrosis Factor 64 RAS MAPK pathway 64 HepDirect R 64 nucleoside analogs 64 proteasome inhibitors 64 sarcoma melanoma 64 camptothecin CPT 64 galiximab 64 oral antiviral 64 novel VDA molecule 64 therapeutic monoclonal antibodies 63 Cobalamin TM mediated 63 tumor xenograft models 63 selectively inhibit replication 63 XL# anticancer compounds 63 MAGE A3 ASCI 63 Elotuzumab 63 preclinical xenograft models 63 anti inflammatory cytokine 63 superficial basal cell carcinomas 63 biologic therapeutics 63 monoclonal antibody MAb 63 investigational humanized monoclonal antibody 63 OncoVex 63 MIF protein 63 NS5b 63 selective antagonists 63 antitumoral 63 Janus kinase 63 Symadex 63 targeted anticancer biopharmaceuticals 63 thalidomide Thalomid 63 memantine HCl 63 c MET 63 ribonucleotide reductase clinically validated 63 Smac mimetics 63 EGFR HER2 63 RECAF TM 63 DURECT proprietary 63 adhesion molecule EpCAM expressing 63 receptor inhibitor 63 CBLC# 63 Vidofludimus 63 BRAF kinase 63 PI3K/Akt pathway inhibitor 63 neovascular diseases 63 AEG# 63 manufactures minimally invasive 63 recurrent metastatic ovarian cancer 63 TRIOLEX HE# APOPTONE HE# 63 Anticalins ® 63 plasma kallikrein 63 Panzem NCD 63 TLR9 agonists 63 A3 adenosine receptor 63 Silodosin 63 Kuvan sapropterin dihydrochloride 63 TTR amyloidosis 63 Crofelemer budesonide foam 63 LRP5 63 inhibit angiogenesis 63 Thiovir 63 Degarelix 63 brand ciclesonide HFA 63 immunomodulatory 63 monoclonal antibody mAb 63 HepDirect prodrug 63 leukotriene pathway 63 Septin9 biomarker 63 Pruvel TM 63 selectively induce apoptosis 63 MEK ERK 63 vitro assay 63 cardio metabolic diseases 63 optical biosensors 63 delta opioid receptor 63 histone deacetylase HDAC 63 NS5B polymerase 63 myeloproliferative disorders 63 POTELLIGENT ® 63 Pseudomonas aeruginosa infections 63 pancreatic colon 63 Interferon alpha 63 bioactive compound 63 biodefense pathogens 63 Xanafide 63 IAP inhibitor 62 Amgen discovers develops 62 CYP#A# CYP#D# 62 polycythemia vera PV 62 Janus Kinase 62 autoantigens 62 NB S# strontium malonate 62 Sapacitabine 62 liposomal formulation 62 samalizumab 62 chemically modified tetracyclines 62 SinuNase ™ 62 immune stimulatory 62 neuroprotective properties 62 5 HT4 62 coronary stent merged 62 tranquilizers diazepam 62 Mg Uk 62 CCR2 receptor 62 CD# expressing 62 CD4 monoclonal antibody 62 Survivin antagonist 62 depsipeptide 62 sapacitabine CYC# 62 BCR ABL inhibitors 62 Miconazole 62 CHEMSAS R 62 Systemic lupus erythematosus SLE 62 cisplatin resistant 62 Deforolimus 62 therapeutic monoclonal antibody 62 Endotoxin Activity Assay 62 cytokines IL 62 TRANSDUR ® 62 Viprovex TM 62 bacterial biothreat agents 62 HSP# inhibitor 62 xenograft models 62 EGFR pathway 62 ALS #-# 62 Ribavirin causes 62 secretory phospholipase A2 62 Nasdaq IMGN biotechnology 62 ChromoCure develops 62 Vidaza ® 62 targeted radiotherapeutic 62 Budesonide foam crofelemer 62 PLX MS 62 cytolytic activity 62 liver colon rectal 62 MSCRAMM ® 62 BioMAP ® Systems 62 IMiDs ® 62 antifungal compounds 62 alpha folate receptor 62 demonstrated antitumor activity 62 tumor hypoxia 62 cosmetic cosmeceutical products 62 ADCC enhanced 62 PR interval prolongation 62 NKG2D 62 cytoprotective 62 Gel repository corticotropin injection 62 endoplasmic reticulum stress 62 HER pathway 62 CTAP# Capsules 62 antiviral antibacterial 62 isotypes 62 modulates Akt 62 Umbilical cord stem cells 62 dasatinib Sprycel ® 62 chemotherapeutic drug 62 small molecule activators 62 FGFR1 62 protein tyrosine phosphatases 62 rheumatoid arthritis juvenile idiopathic 62 Bcr Abl mutations 62 Tyrima 62 protein kinase inhibitor 62 gefitinib Iressa 62 MGd 62 5 HT6 receptor 62 IMiDs R 62 histone deacetylase inhibitor 62 investigational monoclonal antibody 62 synthetic cannabinoid compounds 62 RECAF tm 62 neuronal nicotinic receptor NNR 62 R Saizen R 62 CCR1 62 immunomodulatory properties 62 Mark Burgtorf Quincy 62 pharmacodynamic biomarkers 62 paclitaxel Taxol 62 matrix metalloproteases 62 investigational immunotherapy 62 receptor tyrosine kinase inhibitor 62 Liprotamase 62 novel orally administered 62 virus HCV protease inhibitor 62 biomarker identification 62 metastatic neuroendocrine tumors 62 M2 subunit 62 androgen receptor AR 62 identify protein biomarkers 62 HCV protease 62 IMPACS TM compounds 62 ocular formulation 62 Invasive fungal infections 62 d l leucovorin 62 ImmunoGen TAP technology 62 active AKT inhibitor 62 Epothilones 62 Protein Kinase C 62 epithelial tumors 62 Archexin 62 potent inhibitors 62 interleukins 61 anticancer therapy 61 salinomycin 61 either acutely decompensated 61 Factor Receptor 61 IFN g 61 Epratuzumab 61 inhaled TPI ASM8 61 MKC# MT 61 anionic backbone 61 HCV NS5B polymerase 61 cyclin dependent kinase inhibitor 61 gastro intestinal inflammation 61 APOPTONE 61 Arno Therapeutics 61 4E BP1 61 NS#/#A protease 61 bioinformatic approaches 61 inhibit viral replication 61 DNA methyltransferase inhibitors 61 Aeolus Pharmaceuticals Announces 61 humanized monoclonal antibodies 61 developing Bicifadine serotonin 61 HuMax HepC 61 ZACTIMA TM ZD# 61 S1P antibody 61 B lymphocyte stimulator 61 V#F mutation 61 vinca alkaloid 61 radiolabeled TM# 61 IL #p# 61 Smac mimetic 61 JAK inhibitors 61 Selzentry Celsentri 61 Provectus Pharmaceuticals specializes 61 metabolism viral replication 61 AtuPLEX 61 Invasive pneumococcal disease 61 HuLuc# 61 SIX RO ROG 61 Alfacell proprietary ribonuclease 61 novel immunomodulatory 61 liposomal formulations 61 familial amyloidotic polyneuropathy FAP 61 Mitoxantrone 61 antibiofilm 61 prostanoid 61 biochemical signaling pathways 61 Nanobody 61 product platforms AZX# 61 Angiocept 61 Ganetespib 61 endogenous ligands 61 reversible inhibitor 61 NEUGENE 61 genes gene mutations 61 Lenocta TM sodium stibogluconate 61 Carfilzomib 61 2 methoxyestradiol 61 Methylnaltrexone 61 EGFr expressing metastatic colorectal 61 FGFR 61 γ secretase 61 YONDELIS 61 TRAIL induced apoptosis 61 erlotinib Tarceva R 61 DXL TM antibodies 61 commercializing anti infective 61 selective inhibition 61 cortisol synthesis 61 nonviral gene therapy 61 anticancer compounds 61 DAVANAT 61 HuCAL PLATINUM ® CysDisplay 61 pharmacodynamic profiles 61 adrenergic regulation 61 Anidulafungin 61 Combivir Kivexa 61 tests miRview TM 61 oral transdermal 61 DiLA2 61 monocytes macrophages 61 black salve corrosive 61 CDDO Im 61 Albuferon albinterferon alfa 2b 61 Gleevec resistant 61 CCR9 antagonist 61 attach auristatin 61 TPI ASM8 61 p# alpha [001] 61 DG# compounds targeting 61 thymidylate synthase TS 61 vascular occlusive diseases 61 Orally administered 61 proprietary polysaccharide 61 AKT1 61 commercializing aptamer therapeutics 61 Telik logo TELINTRA 61 RAF kinase 61 Aurora kinase 61 neuronal nicotinic receptors NNRs 61 dasatinib Sprycel 61 TNF receptors 61 ALK inhibitors 61 chimeric monoclonal antibody 61 Vaxfectin TM 61 CYC# 61 vinorelbine tartrate 61 pralatrexate injection folate analogue 61 M1 muscarinic 61 bloodroot shark cartilage 61 Pertuzumab 61 tumor antigens 61 MAPK pathway 61 cyclin dependent kinases 61 p# mitogen activated 61 orally bioavailable mimics 61 peroxidase 61 IL 1Ra 61 oncolytic viruses 61 targeting miR 61 NovaBay Aganocide compounds 61 antiproliferative effects 61 Amplimexon 61 Ovitrelle R Serostim 61 proteasome inhibitor 61 Company TAIFUN R 61 agonistic human 61 Naproxen sodium 61 ON #.Na 61 cancer immunotherapies 61 psoriasis rheumatoid arthritis 61 Chrysalin r rusalatide acetate 61 CXCR4 receptor 61 favorable pharmacokinetic profile 61 hemorrhagic fever viruses 61 Teriflunomide 61 anticancer therapies 61 next generation URAT1 61 highly selective inhibitor 61 Nanobody ® 61 histone deacetylases 61 eTag assays 61 antineoplastic 61 Nutra Pharma wholly owned 61 IMiDs 61 Roche xCELLigence System 61 potent cytotoxic 61 pan HDAC inhibitor 61 OMP #M# 61 Ceflatonin 61 Immunotherapeutic 61 TLR agonists 61 non nucleoside HCV 61 FLT3 61 metaglidasen 61 pharmacodynamic markers 61 LY# [003] 61 products MKC# PP 61 By QianMian #-#-# 61 myeloproliferative diseases 60 infectious diseases autoimmune diseases 60 HER1 60 multiple sclerosis psoriasis 60 investigational antibody 60 liver cancers hypercholesterolemia 60 mTOR inhibitors 60 Signaling Pathway 60 proprietary synthetic peptides 60 silicon carbide SiC gallium 60 rxRNA 60 Pralatrexate 60 small molecule thrombopoietin 60 FULL IMPACT 60 small molecule defensin 60 HQK 60 miRNA biomarkers 60 subtype selective 60 cathepsins 60 prognostic markers 60 potent anticancer 60 Currently Cytheris 60 Darinaparsin 60 Prostacyclin 60 viral hemorrhagic fevers 60 Omacetaxine 60 molecular determinants 60 selective modulator 60 vanA gene 60 small molecule modulators 60 factor TNF 60 splice variants 60 Th2 cytokines 60 CYT# vascular disrupting 60 pancreatic islet beta 60 Sudhir Agrawal D.Phil 60 radiation chemoradiation 60 Antigenics QS 60 AMPK activators 60 5 HT4 agonist 60 PORxin TM platforms 60 OW # NEWS# # 60 SPL# Gel vaginal microbicide 60 Obatoclax 60 reverse vaccinology 60 benign prostatic hypertrophy BPH 60 immunotoxin 60 Safinamide 60 Oracea TM 60 RON Notch 60 Pazopanib 60 metastatic colorectal 60 commercializes implantable 60 Panzem 60 myeloproliferative neoplasms MPNs 60 antiangiogenesis 60 OncoVEX 60 biologic pathway 60 anti fibrotic 60 essential thrombocythemia ET 60 inhibits protein synthesis 60 coagulation disorders 60 CYP#A# substrate 60 Navelbine ® 60 malignant mesothelioma Alfacell 60 Zalypsis 60 antimitotic 60 naturally occurring neuroprotective 60 hereditary emphysema 60 Curaxin CBLC# 60 Zolinza 60 evaluating tivozanib 60 CDK cyclin dependent 60 Panzem R 60 Farfan Juan Pablo 60 CysDisplay R 60 transthyretin TTR 60 Cariprazine 60 molecular abnormalities 60 lipid nanoparticles 60 lung pancreatic 60 commercializing novel biotherapeutics 60 selective inverse agonist 60 tiapamil 60 predictive biomarkers 60 organ transplant rejection 60 mitochondrial toxicity 60 target enzyme thymidylate 60 Schisandrin B 60 Xcytrin R 60 injectable depot 60 antihistamine medicines 60 imatinib Gleevec 60 5 HT2A serotonin 60 Anticholinergic 60 potent topoisomerase II 60 ZACTIMA 60 proliferative diseases 60 immune modulators 60 Provecta TM 60 IL 1β 60 Intravenous Human 60 ATL/TV# 60 Vorinostat 60 BioNeutral antimicrobial formulations 60 MTP inhibitor 60 gastrointestinal stromal 60 rxRNA TM compounds 60 granzyme B 60 fibrate drugs 60 adenosine A2A 60 nucleotide analog 60 Fibrin MB 60 PNP inhibitor 60 lymphotoxin 60 Photodynamic therapy PDT 60 induced mucositis 60 HMG CoA reductase inhibitors 60 hypereosinophilic syndrome 60 MEK inhibitor RDEA# 60 MAP kinases 60 Notch receptors 60 radioactive cesium isotopes 60 psoriasis Crohn disease 60 Litx 60 Tarceva TM 60 RNA antagonist 60 evaluating picoplatin 60 Exelixis compounds 60 immune modulating 60 cleavable linker 60 IL #R 60 Genasense evaluating 60 EOquin TM phase 60 IMA# 60 defensin mimetic antibiotic 60 Vicinium TM 60 biologic pathways 60 antiangiogenic agents 60 necrotizing pneumonia 60 miconazole Lauriad ® 60 Fludara ® 60 JAK2 inhibitors 60 Altera Nebulizer System 60 HemosIL 60 GelSite R polymer 60 Aviptadil 60 MetaBase TM represents 60 pyrimidines 60 Pemetrexed 60 investigational therapies 60 Blinatumomab 60 SAR# [002] 60 FOLOTYN ® 60 polymerase inhibitors 60 Abiraterone acetate 60 chemotherapy induced neutropenia 60 targeted antifolate 60 QUADRAMET R 60 hemagglutination inhibition HAI 60 T#I [002] 60 P#X# antagonist 60 storied chateau 60 triterpenoids 60 Personalized Immunotherapy 60 selective adenosine 60 peptibody 60 serine protease 60 milnacipran HCI 60 solithromycin 60 nucleoside analogues 60 Epstein Barr Virus EBV 60 Intravenous immunoglobulin 60 enzastaurin 60 By JOE SPENCER 60 PROSTASCINT R 60 taxane derivative 60 Leukine ® 60 RNAi therapeutic targeting 60 applying Lipid Sciences 60 TLR antagonists 60 bevacizumab Avastin R 60 Annamycin 60 Afatinib 60 including eniluracil ADH 60 UCB www.ucb group.com 60 basal cell carcinoma squamous 60 Semicondtr 60 Surface Plasmon Resonance SPR 60 Pentad TM 60 CD# antibodies 60 PittsburgKan 60 talabostat 60 verdict elicited gasps 60 #beta HSD 1 60 superantigens 60 nilotinib Tasigna ® 60 molecules Immune SIMULATORS 60 Azedra 60 virus AAV 60 mGluR2 NAM 60 macrocyclic lactone 60 neratinib 60 carbohydrate polymers 60 Gamunex C 60 acetylcholinesterase AChE 60 Anthrax Toxin 60 hydrofluorocarbons potent greenhouse gas 60 factor receptor FGFR 60 S/GSK# 60 ESBA# 60 STAT3 signaling 60 potently inhibit 60 rheumatoid arthritis osteoarthritis ankylosing 60 berberine 60 MitoQ 60 orally administered inhibitor 60 treat male hypogonadism 60 rHuPH# recombinant human 60 Vandetanib 60 intratumoral injection 60 selective antagonist 60 Tumor Necrosis Factor 60 cytotoxic agents 60 tyrosine kinase inhibitors TKIs 60 Atripla combines 60 selective orally bioavailable 60 Poly ICLC 60 novel peptides 60 TLR9 agonist 60 BHT DNA 60 Denny Woodworth Mendon 60 Aptamer 60 papillary renal cell carcinoma 60 THR beta agonist 60 Resurgex Plus R 60 FGFs 60 vorinostat 60 humanized therapeutic 60 biotechnologically 60 Boiling kills 60 Cardium Therapeutics TM 60 protein kinase inhibitors 60 serine threonine 60 bowel syndrome Non 60 Vitaxin 60 tolerability pharmacokinetics 59 pediatric malignancies 59 prodrugs 59 Investigational eFlow Nebulizer System 59 Aurexis R 59 vaccines oncolytic virus 59 recombinant PSMA vaccine 59 Aptocine 59 HCV protease inhibitors 59 systemic juvenile idiopathic 59 Ceflatonin R 59 infectious autoimmune 59 RhuDex R 59 By BEVERLY CORBELL 59 HYVISC ® treatment 59 Trandolapril 59 membrane receptors 59 VOID IN 59 VEGFR2 inhibitor 59 FUSILEV enhances 59 Platinol ® cisplatin 59 fatty acid binding 59 Unstable angina 59 pharmacogenetic test 59 mild vasodilator 59 TTR gene 59 proprietary PEGylation 59 stranded LNA 59 INSPIRE Trial Phase III 59 gastrointestinal mucositis 59 skeletal muscle weakness 59 pentadentate logo R 59 narcotics beta blockers 59 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 59 selectively inhibit 59 alkylating 59 antagomirs 59 RAF kinase VEGFR 59 unresectable tumors 59 IgG1 monoclonal antibody 59 auristatin 59 multitargeted 59 thetreatment 59 3 kinase PI3K 59 JAK2 enzyme 59 Rilonacept 59 MET amplification 59 Bafetinib 59 ATRA IV 59 deCODE AF TM 59 recombinant antibodies 59 targets HGF FGFR 59 reduce serum phosphate 59 carbohydrate polymer 59 Evoltra ® 59 ribosomal RNA rRNA 59 website www.novavax.com 59 diagnostic molecular imaging 59 compound PMX # 59 Ep CAM 59 hypoxia activated prodrug 59 POTELLIGENT ® Technology 59 acne impetigo 59 lipid particles SNALP 59 alvespimycin 59 intranasal delivery 59 TG# [003] 59 mda 7 59 Zemiva TM 59 Tricks Questioned 59 investigational protease inhibitor 59 used DNA alkylating 59 cladribine Cladribine Tablets 59 radiolabeled antibodies 59 human rhinovirus HRV 59 cytolytic 59 small molecule inhibitors 59 AzaSite Xtra 59 markets HP Acthar 59 Helicobacter pylori H. pylori 59 Aplidin R 59 intra abdominal infections 59 PRT# 59 PKC# 59 PMX # heptagonist 59 cathepsin K 59 injectable investigational 59 novel anticancer 59 platform HDL Mimetic 59 mediated apoptosis 59 antiplatelet medications 59 Symbioscience WISDOM PANEL 59 brivanib 59 costimulatory 59 selectively inhibited 59 PROCHYMAL 59 vaginal candidiasis 59 2 inhibitor CYT# 59 PDGF receptor 59 CD# CEA 59 Veronate R 59 GVAX Pancreas Vaccine 59 indibulin 59 Pharmos proprietary 59 Azixa MPC 59 hormone gastrin 59 trastuzumab Herceptin ® 59 protein tyrosine phosphatase 1B 59 antisense inhibitors 59 Platelet Derived Growth 59 Spinal cord stimulation 59 cetuximab Erbitux R 59 serine threonine kinase 59 component EGCG 59 Oragens TM 59 selectively inhibits 59 peptide fragments 59 UsiRNAs 59 NATIONAL ECONOMIC COUNCIL DIRECTOR 59 aptamer therapeutics 59 read Palintologist 59 Anticalins R 59 NPM1 mutation 59 phosphate S1P 59 neuropathic pain metabolic diseases 59 Staphylococcus aureus Immune Globulin 59 selective androgen receptor modulators 59 tetrasodium 59 carcinoma HCC 59 antiplatelet therapies 59 Solazed TM 59 Bucindolol 59 Ganciclovir 59 microtubule inhibitor 59 bifunctional 59 HCV polymerase 59 investigational pharmacologically unique 59 prostaglandin E2 PGE2 59 SGLT2 inhibitors 59 inhibitor PPI 59 Hemopurifier TM 59 adrenocortical cancer 59 R rilonacept Injection 59 Systemic lupus erythematosus 59 busulfan 59 Dementia Related Psychosis 59 YOUR LOCAL ANIMAL SHELTER 59 rxRNA ™ compounds 59 adalimumab Humira 59 CSL Behring therapies 59 Glufosfamide 59 hydrophobic docetaxel prodrug nanoparticle 59 oncologic diseases 59 NASH Huntington 59 Inc. AMEX YMI 59 including HGF ErbB3 59 Eg5 59 candidate deforolimus 59 BY DAVID CRIGGER 59 Amgen discovers develops manufactures 59 immunoregulatory 59 orally inhaled 59 Study Tanning beds 59 leading oral taxane 59 Tezampanel 59 recombinant vaccines 59 Kamada AAT 59 multiplexed assays 59 Tarmogen 59 corticotropin injection 59 triciribine phosphate monohydrate 59 MKC# MKC# PP 59 Thoroughly cooking eggs 59 advanced metastatic renal 59 genomic biomarkers 59 WEALTH MINERALS LTD 59 INxin TM 59 tubulin inhibitor 59 underlying vasculopathy 59 epothilones 59 kinase inhibition 59 oral JAK1 59 refractory chronic myeloid 59 intracellular signaling pathways 59 hPTH #-# 59 visiting http:/www.westell.com 59 tumor subtypes 59 bone marrow lymph nodes 59 somatostatin 59 Initiates Enrollment 59 HAAH 59 small molecule tyrosine 59 HER2 ErbB2 59 HDAC inhibition 59 biologic DMARD 59 bendamustine HCl 59 prokinetic agent 59 colorectal ovarian endometrial 59 GTC recombinant human 59 RhuDex ® 59 taste masking orally 59 Chemokine Receptor 59 Affibody ® molecules 59 zanolimumab 59 nanomolar 59 glycolipids 59 ALVESCO ® 59 IMiDs ® compound 59 Aplidin 59 MyVax R 59 oral candidiasis 59 BChE 59 deCODE ProstateCancer TM 59 hereditary deficiency 59 EGFr 59 systemic fungal infections 59 anti leukemic 59 TAFA# 59 ADP receptor antagonist 59 gastrointestinal disorders ATI 59 TM Aganocide 59 ganetespib 59 radezolid 59 PD2i CA Cardiac Analyzer 59 inactivated strain 59 MediGene focuses 59 molecularly targeted 59 tramiprosate Alzhemed TM 59 By PETER LARSEN 59 solid tumors ZYBRESTAT 59 Exosome Sciences 59 oleanolic acid 59 XL# inhibits 59 immunomodulator 59 Ms. Oddis 59 hyperphosphorylation 59 XmAb# 59 personalized cellular immunotherapy 59 genetic biomarkers 59 Skinvisible receives 59 panitumumab Vectibix 59 cyclin dependent kinase CDK 59 antisense inhibition 59 novel therapeutic antibodies 59 huC# DM4 59 Imatinib mesylate 59 Adenoviruses usually cause 59 Glucocorticoids 59 basophils 59 hypermethylated 59 serine proteases 59 FOLFOX6 chemotherapy regimen 59 Sezary syndrome 59 contracting activity F#-#-C-#/P# 59 PCA3 gene 59 topical gel formulation 59 lapatinib Tykerb 59 commercialize Aganocides 59 Avise MCV SM 59 novel oral tubulin 59 renal failure interstitial lung 59 non porcine pancreatic 59 colorectal lung 59 RONDEL TM 59 Mucosal 59 4SC AG ISIN DE# 59 small molecule glucokinase 59 Interferon gamma 59 enhanced skin permeation 59 Nasdaq AEGR 59 ® bortezomib 59 BCG refractory carcinoma 59 GLASSIA 59 silico prediction 59 G Protein Coupled 59 CYTEC INDUSTRIES 59 nanoviricides 59 VEGF receptor 59 vitamin B# folic acid 59 neutrophil gelatinase associated lipocalin 59 reverse transcriptase inhibitors 59 lipid abnormalities 59 GED aPC 59 tyrosine kinase receptor 59 MDR Gram negative 59 Seliciclib 59 paclitaxel Taxol ® 59 pDC 59 glucocerebroside primarily 59 bacterium Streptococcus pneumoniae 59 preclinical studies Vion 59 specific CCR9 antagonist 59 membranous nephritis 59 Fc fusion protein 59 Pharmos pipeline 59 effector function 59 ovarian pancreatic 59 molecular imaging radiopharmaceuticals 59 relapsed leukemia